The venture investing platform of Israel OurCrowd stated on Tuesday that it plans to raise $100 million for the investment in technology in medical, education, and other segments for finding solutions for coronavirus or COVID-19 and future pandemics. Read more...
Read MoreToday, OurCrowd announces the launch of its Pandemic Innovation Fund. We plan to raise $100 million for investment in urgent technological solutions for the medical, business, educational and social needs triggered by global pandemics and other health emergencies. Read more...
Read MoreMorphisec has been tracking an uptick in the delivery of Ursnif/Gozi during the COVID-19 pandemic. Specifically, we have noticed a significant spike both in numbers and sophistication. Read...
Read MoreAs the number of worldwide deaths from the coronavirus nears 400,000, the crowdfunding platform OurCrowd has launched a $100 million Pandemic Innovation Fund. In a blog post on Tuesday (June 2), CEO Jonathan Medved said the fund will provide cash to companies working to develop treatments, vaccinations and cures for COVID-19 and future pandemics, as well as those providing solutions for the fundamental changes in the economy and society caused by the crisis. Read more...
Read MoreIsraeli health company MeMed Diagnostics Ltd., which developed a test that can identify whether an infection was caused by a virus or bacteria thus significantly reducing the use of antibiotics for treatment, has received regulatory approval to put its rapid test, which can provide results within 15 minutes, on the Israeli and European market. Read more...
Read More
